Literature DB >> 21709135

Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Kim E Innes1, Alan M Ducatman, Michael I Luster, Anoop Shankar.   

Abstract

Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that affect metabolic regulation, inflammation, and other factors implicated in the pathogenesis of osteoarthritis (OA). However, the link between these compounds and OA remains unknown. In this study, the authors investigated the association of OA with PFOA and PFOS in a population of 49,432 adults from 6 PFOA-contaminated water districts in the mid-Ohio Valley (2005-2006). Participants completed a comprehensive health survey; serum levels of PFOA, PFOS, and a range of other blood markers were also measured. Medical history, including physician diagnosis of osteoarthritis, was assessed via self-report. Analyses included adjustment for demographic and lifestyle characteristics, body mass index, and other potential confounders. Reported OA showed a significant positive association with PFOA serum levels (for highest quartile of PFOA vs. lowest, adjusted odds ratio = 1.3, 95% confidence interval: 1.2, 1.5; P-trend = 0.00001) and a significant inverse association with PFOS (for highest quartile vs. lowest, adjusted odds ratio = 0.8, 95% confidence interval: 0.7, 0.9; P-trend = 0.00005). The relation between PFOA and OA was significantly stronger in younger and nonobese adults. Although the cross-sectional nature of this large, population-based study limits causal inference, the observed strong, divergent associations of reported OA with PFOA and PFOS may have important public health and etiologic implications and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709135      PMCID: PMC3202163          DOI: 10.1093/aje/kwr107

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  57 in total

1.  Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells.

Authors:  Kirsten Thorup Eriksen; Ole Raaschou-Nielsen; Mette Sørensen; Martin Roursgaard; Steffen Loft; Peter Møller
Journal:  Mutat Res       Date:  2010-05-06       Impact factor: 2.433

2.  Postmenopausal estrogen and increased risk of clinical osteoarthritis at the hip, hand, and knee in older women.

Authors:  Denise Von Mühlen; Deborah Morton; Carlos A Von Mühlen; Elizabeth Barrett-Connor
Journal:  J Womens Health Gend Based Med       Date:  2002 Jul-Aug

3.  Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Authors:  Stephanie J Frisbee; Anoop Shankar; Sarah S Knox; Kyle Steenland; David A Savitz; Tony Fletcher; Alan M Ducatman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-09

Review 4.  The role of uric acid and other crystals in osteoarthritis.

Authors:  Johannes Nowatzky; Rennie Howard; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

5.  Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.

Authors:  Scott M Bartell; Antonia M Calafat; Christopher Lyu; Kayoko Kato; P Barry Ryan; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

6.  Self-reported arthritis among men and women in an adult community.

Authors:  T L Holbrook; D L Wingard; E Barrett-Connor
Journal:  J Community Health       Date:  1990-06

Review 7.  PPARalpha in atherosclerosis and inflammation.

Authors:  Fokko Zandbergen; Jorge Plutzky
Journal:  Biochim Biophys Acta       Date:  2007-05-21

8.  Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?

Authors:  Peter R Kornaat; Ruby Sharma; Rob J van der Geest; Hildo J Lamb; Margreet Kloppenburg; Marie-Pierre Hellio le Graverand; Johan L Bloem; Iain Watt
Journal:  Skeletal Radiol       Date:  2009-07-03       Impact factor: 2.199

9.  Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.

Authors:  Antonia M Calafat; Lee-Yang Wong; Zsuzsanna Kuklenyik; John A Reidy; Larry L Needham
Journal:  Environ Health Perspect       Date:  2007-11       Impact factor: 9.031

10.  The C8 health project: design, methods, and participants.

Authors:  Stephanie J Frisbee; A Paul Brooks; Arthur Maher; Patsy Flensborg; Susan Arnold; Tony Fletcher; Kyle Steenland; Anoop Shankar; Sarah S Knox; Cecil Pollard; Joel A Halverson; Verónica M Vieira; Chuanfang Jin; Kevin M Leyden; Alan M Ducatman
Journal:  Environ Health Perspect       Date:  2009-07-13       Impact factor: 9.031

View more
  8 in total

1.  Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.

Authors:  Yong Zhao; Ying S Tan; Mark J Strynar; Gloria Perez; Sandra Z Haslam; Chengfeng Yang
Journal:  Reprod Toxicol       Date:  2012-03-05       Impact factor: 3.143

2.  Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA): emerging contaminants of increasing concern in fish from Lake Varese, Italy.

Authors:  S Squadrone; V Ciccotelli; M Prearo; L Favaro; T Scanzio; C Foglini; M C Abete
Journal:  Environ Monit Assess       Date:  2015-06-18       Impact factor: 2.513

Review 3.  Pollutants: a candidate as a new risk factor for osteoarthritis-results from a systematic literature review.

Authors:  Camille Deprouw; Alice Courties; Jean-Baptiste Fini; Marie-Stéphanie Clerget-Froidevaux; Barbara Demeneix; Francis Berenbaum; Jérémie Sellam; Karine Louati
Journal:  RMD Open       Date:  2022-06

Review 4.  A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans.

Authors:  Ellen T Chang; Hans-Olov Adami; Paolo Boffetta; H James Wedner; Jack S Mandel
Journal:  Crit Rev Toxicol       Date:  2016-01-13       Impact factor: 5.635

5.  Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008.

Authors:  Sarah A Uhl; Tamarra James-Todd; Michelle L Bell
Journal:  Environ Health Perspect       Date:  2013-02-14       Impact factor: 9.031

6.  Association Between Drinking Water Sources and Osteoarthritis Incidence in Chinese Elderly Population: National Population-Based Cohort Study.

Authors:  Yangchang Zhang; Tingting Wu; Shisi Shen; Yang Xiong; Xu Wang; Jialu Yang; Xirui Chen; Yanjun Lu; Xun Lei
Journal:  Front Med (Lausanne)       Date:  2022-02-03

7.  No association between perfluoroalkyl chemicals and hypertension in children.

Authors:  Sarah Dee Geiger; Jie Xiao; Anoop Shankar
Journal:  Integr Blood Press Control       Date:  2014-01-13

Review 8.  Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances.

Authors:  Alexis M Temkin; Barbara A Hocevar; David Q Andrews; Olga V Naidenko; Lisa M Kamendulis
Journal:  Int J Environ Res Public Health       Date:  2020-03-04       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.